Century Therapeutics Growth Metrics (2020-2026) | IPSC

Growth Metrics Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
0.20M-3.13M-2.08M-0.83M-0.16M2.95M1.84M1.33M0.34M
EBITDA Margin Growth (3y) (Quarter)
0.38M
EBITDA Margin (QoQ) (Quarter)
0.15M0.09M-0.45M0.41M-3.18M1.14M0.80M1.09M-0.07M0.02M0.29M0.09M
EBIT Margin Growth (1y) (Quarter)
0.17M-3.32M-2.26M-0.99M-0.18M3.09M1.97M1.81M0.37M
EBIT Margin Growth (3y) (Quarter)
0.36M
EBIT Margin (QoQ) (Quarter)
0.13M0.08M-0.50M0.45M-3.36M1.14M0.77M1.27M-0.08M0.01M0.62M-0.17M
EBT Margin Growth (1y) (Quarter)
0.18M-3.04M-2.03M-0.90M-0.15M2.86M1.78M1.42M0.34M
EBT Margin Growth (3y) (Quarter)
0.36M
EBT Margin (QoQ) (Quarter)
0.13M0.08M-0.47M0.43M-3.09M1.10M0.67M1.17M-0.08M0.01M0.31M0.09M
Enterprise Value Growth (1y) (Quarter)
-194.22%4.73%-20.57%-41.56%30.34%58.71%52.37%45.25%23.64%-25.58%-16.88%-9.58%-52.78%20.65%-3.07%10.96%54.05%
Enterprise Value Growth (3y) (Quarter)
-31.62%20.95%12.44%5.30%6.68%25.62%16.90%18.86%18.77%
Enterprise Value Growth (5y) (Quarter)
-17.35%
Enterprise Value (QoQ) (Quarter)
25.76%24.49%-61.98%-4.91%6.05%11.34%20.29%37.81%-8.38%-1.91%-11.16%-2.28%-0.87%4.45%-54.98%46.88%-31.03%17.46%20.02%
FCF Margin Growth (1y) (Quarter)
-0.98M-2.24M-0.93M-0.99M-0.16M2.04M0.78M0.96M0.36M
FCF Margin Growth (3y) (Quarter)
-0.79M
FCF Margin (QoQ) (Quarter)
-0.94M-0.06M0.19M-0.18M-2.20M1.26M0.13M0.66M0.00M-242.000.30M0.05M
Interest Coverage Ratio Growth (1y) (Quarter)
72.51%-91.90%-107.26%-31.23%-33.68%40.56%22.68%-171.49%
Interest Coverage Ratio (QoQ) (Quarter)
-25.85%-10.80%-8.65%-36.81%20.31%-12.86%51.69%-77.97%-179.78%
Net Margin Growth (1y) (Quarter)
0.17M-3.14M-2.07M-0.86M-0.15M2.96M1.82M1.39M0.34M
Net Margin Growth (3y) (Quarter)
0.36M
Net Margin (QoQ) (Quarter)
0.13M0.08M-0.47M0.43M-3.18M1.15M0.74M1.14M-0.08M0.01M0.31M0.09M
Operating Margin Growth (1y) (Quarter)
0.17M-3.32M-2.26M-0.99M-0.18M3.09M1.97M1.81M0.37M
Operating Margin Growth (3y) (Quarter)
0.36M
Operating Margin (QoQ) (Quarter)
0.13M0.08M-0.50M0.45M-3.36M1.14M0.77M1.27M-0.08M0.01M0.62M-0.17M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets Growth (3y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
-819.00-685.00-474.00-808.00-923.00-0.00M-0.00M-837.00-261.000.00M0.01M0.01M0.01M990.00-0.01M
Return on Capital Employed Growth (3y) (Quarter)
-0.00M0.00M0.00M0.01M0.01M0.00M-923.00
Return on Capital Employed (QoQ) (Quarter)
-391.00-255.0063.00-237.00-257.00-44.00-271.00-351.00-539.00-250.00303.00225.000.00M0.00M305.00433.00-0.00M-0.00M
Return on Equity Growth (1y) (Quarter)
-1.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M1.001.000.00M1.000.00M
Return on Equity Growth (3y) (Quarter)
-1.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Equity Growth (5y) (Quarter)
-1.00
Return on Equity (QoQ) (Quarter)
-1.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M1.000.00M0.00M0.00M0.00M
Return on Invested Capital Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M1.00
Return on Invested Capital (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M1.00
Return on Sales Growth (1y) (Quarter)
17.00-314.00-207.00-86.00-15.00296.00182.00139.0034.0040.0039.008.00
Return on Sales Growth (3y) (Quarter)
36.0022.0014.0061.00
Return on Sales (QoQ) (Quarter)
13.008.00-47.0043.00-318.00115.0074.00114.00-8.001.0031.009.00-1.000.00M0.00M